Old Web
English
Sign In
Acemap
>
Paper
>
P600 Vedolizumab dose optimisation: Findings from a Belgian registry
P600 Vedolizumab dose optimisation: Findings from a Belgian registry
2020
Edward E. Louis
V. Muls
Patrick M. M. Bossuyt
A. Colard
A. Nakad
D. Baert
Fazia Mana
Philip Caenepeel
S. Vanden Branden
S Vermeire
F D'Heygere
B. Strubbe
A. Cremer
Jc Coche
V. Setakhr
F Baert
A. Vijverman
J.-L. Coenegrachts
F. Flamme
A Hantson
K Wijnen
E Piters
G Hantsbarger
P. Dolin
Keywords:
Gastroenterology
Ulcerative colitis
Disease remission
Physical therapy
Crohn's disease
Anti-Tumor Necrosis Factor Therapy
Vedolizumab
Internal medicine
Diabetes mellitus
Inflammatory bowel disease
Medicine
Irritable bowel syndrome
dose optimisation
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
1
Citations
NaN
KQI
[]